ARCHIVES

IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes

This article is from The Cancer Letter archive.

Vol. 19 No. 10 | March 5, 1993

Download PDF Visit The Full Archive

Related Articles

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010

What Would You Tell a 45-Year-Old? Waxman Asks Broder

February 4, 1994

In Brief: Fishman La Jolla President Emeritus, Ruoslahti Succeeds Him; Ariz. Seeks Meyskins Replacement

January 13, 1989

NCI Supports Development Of Reinoids for Prevention; No Magic Bullet

May 6, 1977

Hugh Creech, Fox Chase Chemotherapy Pioneer, Dead at 92

January 31, 2003

Finasteride Cut Risk Of Prostate Cancer In Large Trial, But Value In Clinic Unclear.

June 27, 2003